[DOI] [PMC free article] [PubMed] [Google Scholar] 107.The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome
Burning could be a reaction to the injection or to the medication itself, so you will need to keep an eye on your reaction
Clinical studies suggest GLP-1s are effective not only at helping patients lose weight, but also at reducing the risk of other conditions, such as cardiovascular and kidney disease
Known and novel pathways of metabolic dysfunction, previously relevant in older populations or animal models, such as transcriptional regulation, brain-derived neurotrophic factor (BDNF), nitric oxide, and renin-angiotensin pathways, have been recognized in young adults at risk for coronary issues 6